Quest Diagnostics Inc.
DGXStock
$209.41+21.24%52W
Market Cap$22.89B
P/E23.08x
Div yield1.70%
Beta0.56
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)3.81%
Price vs S&P 500 (4W)-0.23%
VGM Score46.45
Market Capitalization$22.89B
P/E Ratio (Annual)23.08x
Indicated Dividend Yield (Annual)1.70%
Earnings Surprise History
Q1 262.50est. 2.37
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
3.79
3.79
3.79
3.83
Industry Peers — Health Services(29)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
DGXQuest Diagnostics Inc. | C | D | C | $209.41 |
| NTRANatera, Inc. Common Stock | F | A | B | $269.83 |
| LHLabcorp Holdings Inc. | C | D | C | $281.94 |
| GHGuardant Health, Inc. Common Stock | F | A | A | $155.00 |
| EXASExact Sciences Corp | F | B | B | $0.00 |
| BLLNBillionToOne, Inc. Class A Common Stock | F | F | B | $128.18 |
| RDNTRadNet, Inc. Common Stock | D | C | C | $62.99 |
| CAICaris Life Sciences, Inc. Common Stock | F | A | D | $16.48 |
| VCYTVeracyte, Inc. | D | A | A | $59.22 |
| CELCCelcuity Inc. Common Stock | — | — | B | $88.29 |
| GRALGRAIL, Inc. Common Stock | D | A | B | $71.96 |
About
Quest Diagnostics is the leading independent provider of diagnostic testing services in the United States, generating over 97% of revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse screening delivered via a nationwide network of approximately 2,400 patient service centers and partnerships with healthcare providers. The company's diagnostic solutions segment provides supplementary services including clinical trials testing, risk-assessment services, and healthcare information technology solutions.